GET ALL THE ACCESS

Publications

06/03/2024
In The New York Times, Beneva’s Bruno Rasmussen Discusses Ibogaine
Ibogaine, a psychedelic substance derived from the root of a shrub found in regions of Africa, has been gaining increasing interest among scientists. A report from […]
28/11/2023
Ibogaine Treatment at Beneva is One of the Best in the World, According to ‘Healing Maps’
The website Healing Maps listed Beneva as one of the world’s best ibogaine treatment centers.  In order to create the list, the site consulted with iboga […]
24/10/2023
The Legacy of Roland Griffiths: Exploring Psychedelics and the Meaning of Life
Psychopharmacologist Roland Griffiths was one of the most respected researchers in the field of consciousness-altering substance studies. His research contributed to the emergence of the current […]
23/06/2023
Psychedelic Rock Star: Pioneer Rick Doblin Receives Ovation at ‘Psychedelic Science 2023’
The Psychedelic Science conference started this Wednesday with a big ovation for Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), considered one of […]
21/06/2023
Nature: Psychedelics Can Help Reopen Childhood Learning Windows
A study published in Nature has shown that psychedelics can reopen learning windows in the brain, known as “critical periods,” which typically occur during childhood. This […]
06/06/2023
The New Brand of Beneva Brings More Fluidity and Balance
We are excited to share the development of our clinic. To align with the needs and expectations of our patients, we have given our brand a […]
30/05/2023
Ketamine Can Treat Depression as Effectively as ECT without Causing Memory Loss
Ketamine infusion may be as effective as electroconvulsive therapy (ECT) for individuals with treatment-resistant depression who do not have psychosis. Under certain conditions, it even offers […]
28/05/2023
Ketamine May Reduce Symptoms of Borderline Personality Disorder
A new study published in the journal Psychiatry Research suggests that ketamine may be a valid treatment option for individuals with borderline personality disorder (BPD) associated […]
25/05/2023
Ketamine vs. Electroconvulsive Therapy: Which is More Effective for Depression
Electroconvulsive therapy (ECT) is a treatment option for individuals with mental disorders who have not found positive results with traditional methods. Despite its historical association with […]
24/05/2023
John Krystal, the History of Ketamine, and a New Paradigm for Depression
One of the most anticipated lectures at the annual meeting of the American Psychiatric Association (APA) in 2023 was given by Dr. John H. Krystal, Director […]
27/04/2023
The Guardian: A New Era of Psychedelics Approaches With Legal Use Permitted in Australia
As more studies demonstrate the therapeutic benefits of psychedelics, these substances should become more prevalent in society.. The question, as Dr. Farrah Jarral wrote in The […]
24/04/2023
Time Magazine: Can Psychedelics Treat Long COVID?
Can psychedelics treat Long COVID? A report from Time magazine, written by journalist Jamie Ducharme, sought to answer this question based on the stories of patients […]